Pulmonary arterial hypertension (PAH) is a severe medical condition characterized by
elevated pulmonary vascular resistance (PVR), right ventricular (RV) failure, and death in …

Current knowledge of pulmonary arterial hypertension (PAH) epidemiology is based mainly
on data from Western populations, and therefore we aimed to characterize a large group of …

Atherothrombosis is the principal underlying cause of cardiovascular disease (CVD).
Microvesicles (MV) are small blebs originated by an outward budding at the cell plasma …

Background Recent studies revealed that alterations in glucose and lipid metabolism in
idiopathic pulmonary arterial hypertension (IPAH) are associated with disease severity and …

Abstract Corydalis saxicola Bunting (Yanhuanglian), distributed in Southwest China, is
mainly used for treatment of hepatitis, oral mucosal erosion, conjunctivitis, dysentery, acute …

Background Although previous studies have reported the gut microbiome is closely related
to hypertension development, whether the change in blood microbiome is associated with …

Background Pulmonary hypertension and right ventricular (RV) dysfunction are drivers of
adverse outcomes; however, modifiable risk factors for RV dysfunction are not well …

Idiopathic pulmonary arterial hypertension (IPAH) is a progressive disease that affects the
pulmonary arteries, resulting in increased pulmonary vascular resistance and right …

Objective The significance of apolipoprotein AI (ApoA-I) is the anti-inflammatory functional
component of high-density lipoprotein, which needs to be further studied in relation to …

Lipid homeostasis is dysregulated in pulmonary arterial hypertension (PAH). A decrease in
serum high-and low-density lipoprotein cholesterol (HDL-C and LDL-C) is significantly …